| Robert William Duggan |
Mr. Robert W. Duggan is an Executive Chairman & Co-Chief Executive Officer at Summit Therapeutics, Inc., an Executive Chairman at Pulse Biosciences, Inc., a Chief Executive Officer at Pharmacyclics, Inc., a Chief Executive Officer at Duggan Investments Inc. and an Executive Chairman & Co-Chief Executive Officer at Summit Therapeutics Ltd. He is on the Board of Directors at Discuva Ltd., Human Longevity, Inc., MuOx Ltd., Santa Barbara Foundation and University of California Santa Barbara Foundation. Mr. Duggan was previously employed as a Chairman & Chief Executive Officer by Pharmacyclics, Inc., a Chairman & Chief Executive Officer by Computer Motion, Inc., a Chairman by Communication Machinery Corp., a Chairman by Metropolis Media, Inc., and a President by Robert W. Duggan & Associates. He also served on the board at Intuitive Surgical, Inc., GTSI Corp. and AM-CH, Inc. |
| Mitchell E. Levinson |
Mitchell E. Levinson was the founder of ZELTIQ Aesthetics, Inc. (founded in 2005) where he held the title of Chief Scientific Officer from 2009 to 2010. He is also the founder of Cerebrotech Medical Systems, Inc. (founded in 2010) where he currently holds the title of Director & Chief Technology Officer. Mr. Levinson's current job is as the Chief Strategy Officer at Pulse Biosciences, Inc. (since 2019). Mr. Levinson's former jobs include being a Director-Product Development at Nellcor Puritan Bennett, Inc., an Independent Director at Pulse Biosciences, Inc. (from 2015 to 2017), and a Principal at Arconic, Inc., Baxter Healthcare Corp., and HP, Inc. He was also the Vice President-Research & Development at Thermage, Inc. (from 2000 to 2005) and the Vice President-Engineering at BioSurgical Corp.Mr. Levinson completed his undergraduate degree at the University of California San Diego and his graduate degree at the University of Phoenix. |
| Dunnington Gansevoort |
Dunnington Gansevoort is currently the Chief Medical Officer at Pulse Biosciences, Inc. Prior to this, he obtained a doctorate degree from the Medical College of Virginia. |
| David Danitz |
David Danitz is currently the Senior Vice President-Engineering at Pulse Biosciences, Inc. He previously held positions as Principal at Computer Motion, Inc., Vice President-Research & Development at Gynesonics, Inc., Vice President-Research & Development at Earlens Corp., Vice President-Research & Development at Novare Surgical Systems, Inc., and Principal at Exxon Production Research Co. Mr. Danitz has a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California, Santa Barbara. |
| Edison Manuel |
Edison Manuel currently works at Pulse Biosciences, Inc., as Vice President-Operations from 2017. Mr. Manuel also formerly worked at Computer Motion, Inc., as Operations Director, RITA Medical Systems, Inc., as Operations Director from 2003 to 2007, Novare Surgical Systems, Inc., as Vice President-Operations & Manufacturing from 2007 to 2011, Stellartech Research Corp., as Vice President-Manufacturing Operations from 2011 to 2014, and Progyny, Inc., as Vice President-Operations from 2014 to 2016. Mr. Manuel received his undergraduate degree from Mapua Institute of Technology. |
| Richard Nuccitelli |
Richard Nuccitelli founded BioElectroMed Corp. in 2001. Dr. Nuccitelli also currently works at Pulse Biosciences, Inc., as Chief Science Officer. Dr. Nuccitelli also formerly worked at Old Dominion University, as Professor from 2004 to 2007 and the University of California, Davis, as Professor from 1978 to 2001. Dr. Nuccitelli received his graduate degree and doctorate degree from Purdue University. |
| William Knape |
William Knape is currently the Vice President-Clinical, Regulatory & Quality at Pulse Biosciences, Inc. He obtained his undergraduate degree from the University of Wyoming. |
| Kevin P. Danahy |
Kevin P. Danahy currently works at Pulse Biosciences, Inc., as Chief Commercial Officer from 2024. Mr. Danahy also formerly worked at Intuitive Surgical, Inc., as Senior Director from 2010 to 2014, Solmetex LLC, as President from 2019 to 2022, and Zimmer US, Inc., as VP-Global Emerging Technologies & Specialty Sales from 2017 to 2019. Mr. Danahy received his graduate degree from Tufts University. |
| Darrin R. Uecker |
Darrin R. Uecker is currently the Director & Chief Technology Officer at Pulse Biosciences, Inc. He previously held positions as the President & Chief Executive Officer at Gynesonics, Inc. from 2009 to 2014, Senior Vice President at Conceptus, Inc. from 2007 to 2008, Chief Technology Officer at Computer Motion, Inc. from 2001 to 2003, Chief Technical Officer at RITA Medical Systems, Inc. from 2004 to 2007, and Senior Vice President at CyberHeart, Inc. from 2008 to 2009. He also served as the Chief Operating Officer at Auxogyn, Inc. and as the President & Chief Operating Officer at Progyny, Inc. from 2014 to 2015. Mr. Uecker completed his undergraduate and graduate degrees at the University of California, Santa Barbara. |
| Burke T. Barrett |
Burke T. Barrett is currently the President, Co-Chief Executive Officer & Director at CardioFocus, Inc. and the President, Chief Executive & Financial Officer at Pulse Biosciences, Inc. He previously worked as the Director-Regulatory & Clinical Affairs at MacKay Life Sciences, Inc., Dornier Medical Systems, Inc., and Bausch & Lomb, Inc. He also served as the VP-Technology & Business Development at LivaNova USA, Inc. from 1997 to 2002. Additionally, he held positions as the Vice President-Clinical Operations at Trafalgar Ventures, Inc. and Cyberkinetics Neurotechnology Systems, Inc. Mr. Barrett received his undergraduate degree from Syracuse University in 1985 and his MBA from Kennesaw State University in 1992. |
| Manmeet Singh Soni |
Mr. Manmeet Singh Soni, CPA, is a Director, Chief Operating & Financial Officer at Summit Therapeutics, Inc. and a Lead Independent Director at Pulse Biosciences, Inc. He is on the Board of Directors at Summit Therapeutics Ltd., Summit Therapeutics, Inc. and Pulse Biosciences, Inc. Mr. Soni was previously employed as a President, Chief Operating & Financial Officer by Reata Pharmaceuticals, Inc., an Independent Non-Executive Director by Arena Pharmaceuticals, Inc., a Senior VP, Chief Financial & Accounting Officer by Alnylam Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by ARIAD Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by Pharmacyclics, Inc., a Chief Financial Officer by Pharmacyclics, Inc., a Senior Director-Finance & Controller by ZELTIQ Aesthetics, Inc., and a Senior Manager-Life Science by PricewaterhouseCoopers LLP. He also served on the board at Genoscience Pharma. He received his undergraduate degree from Hansraj College. |
| Richard van den Broek |
Richard van den Broek founded HSMR Advisors LLC in 2004, where he is working as Managing Partner from 2012. Mr. van den Broek also currently works at PhaseBio Pharmaceuticals, Inc., as Independent Director from 2019, Cogstate Ltd., as Independent Non-Executive Director from 2010, and Pulse Biosciences, Inc., as Independent Director from 2020. Mr. van den Broek also formerly worked at Pharmacyclics LLC, as Independent Director from 2009 to 2015, Standard Diversified, Inc., as Independent Director from 2011 to 2015, Syntara Ltd., as Non-Executive Director from 2009 to 2013, Response Genetics, Inc., as Independent Director from 2010 to 2015, Amerisur Resources Ltd., as Non-Executive Director, Celldex Therapeutics, Inc., as Independent Director from 2014 to 2016, Pharmacyclics, Inc., as Director from 2009 to 2015, Cooper Hill Partners LLC (Investment Management), as Partner from 2000 to 2003, and Oppenheimer & Co., Inc., as Biotech Analyst. Mr. van den Broek received his undergraduate degree from Harvard University. |
| Mahkam Zanganeh |
Mahkam Zanganeh is the founder of Maky Zanganeh & Associates, Inc. (founded in 2015) where she holds the title of Chief Executive Officer & Director. She is currently the President, Co-Chief Executive Officer & Director at Summit Therapeutics Ltd. (since 2020), Summit Therapeutics, Inc. (since 2020), and Director at Image-Guided Hybrid Surgery Institute. She is also an Independent Director at Pulse Biosciences, Inc. (since 2017). Dr. Zanganeh previously served as an Independent Director at RenovoRx, Inc. (2018-2021), Director at Oxstem Ltd., Director at Human Longevity, Inc., Chief Operating Officer at Pharmacyclics LLC (2012-2015), Vice President-Worldwide Training & Education at Computer Motion, Inc. (2002-2003), Vice President-Business Development at Robert W. Duggan & Associates (2008), and Chief Operating Officer at Pharmacyclics, Inc. (2012-2015). She holds an MBA from Schiller International University (France) and a doctorate from Louis Pasteur University. |
